These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31938603)

  • 1. Hydroxyurea-induced Tongue Hypermelanosis and Transverse Melanonychia.
    Neculiseanu E; Harewood J; Sidhu G
    Cureus; 2019 Dec; 11(12):e6311. PubMed ID: 31938603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanonychia and mucocutaneous hyperpigmentation from hydroxyurea use for the treatment of essential thrombocytosis.
    Karanth SS; Gupta A; Prabhu M
    Singapore Med J; 2014 Jan; 55(1):e7-8. PubMed ID: 24452985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject.
    Saraceno R; Teoli M; Chimenti S
    Clin Ther; 2008 Jul; 30(7):1324-9. PubMed ID: 18691992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-Onset Hydroxyurea-Induced Melanonychia and Tongue Hyperpigmentation in a Patient With Polycythemia Vera: A Case Report.
    Letete N; Vaz D
    Cureus; 2024 Feb; 16(2):e53642. PubMed ID: 38449930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous manifestations of hydroxyurea therapy in childhood: case report and review.
    Issaivanan M; Mitu PS; Manisha C; Praveen K
    Pediatr Dermatol; 2004; 21(2):124-7. PubMed ID: 15078351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-Nail Transverse Melanonychia Induced by Hydroxyurea: Case Report and Review of the Literature.
    Osemwota O; Uhlemann J; Rubin A
    J Drugs Dermatol; 2017 Aug; 16(8):814-815. PubMed ID: 28809997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic mucocutaneous toxicity of hydroxyurea in Philadelphia chromosome-negative myeloproliferative neoplasms: the Mister Hyde face of a safe drug.
    Latagliata R; Spadea A; Cedrone M; Di Giandomenico J; De Muro M; Villivà N; Breccia M; Anaclerico B; Porrini R; Spirito F; Rago A; Avvisati G; Alimena G; Montanaro M; Andriani A;
    Cancer; 2012 Jan; 118(2):404-9. PubMed ID: 21692060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal, transverse, and diffuse nail hyperpigmentation induced by hydroxyurea.
    Hernández-Martín A; Ros-Forteza S; de Unamuno P
    J Am Acad Dermatol; 1999 Aug; 41(2 Pt 2):333-4. PubMed ID: 10426924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous ulcers associated with hydroxyurea therapy in myeloproliferative disorders.
    Ravandi-Kashani F; Cortes J; Cohen P; Talpaz M; O'Brien S; Markowitz A; Kantarjian H
    Leuk Lymphoma; 1999 Sep; 35(1-2):109-18. PubMed ID: 10512168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyurea-induced superinfected ulcerations: Two case reports and review of the literature.
    Iancu GM; Ocneanu A; Rotaru M
    Exp Ther Med; 2020 Dec; 20(6):191. PubMed ID: 33101481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal melanonychia associated with hydroxyurea therapy in a patient with essential thrombocytosis.
    Cohen AD; Hallel-Halevy D; Hatskelzon L; Peretz E; Halevy S
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):137-9. PubMed ID: 10568495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyurea-induced melanonychia.
    Buontempo MG; Chaudhry ZS; Raval RS; Mourtzanakis K; Ramachandran V; Shapiro J; Lo Sicco K
    JAAD Case Rep; 2023 Dec; 42():91-94. PubMed ID: 38090663
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxyurea Associated Cutaneous Lesions: A Case Report.
    Simeonovski V; Breshkovska H; Duma S; Dohcheva-Karajovanov I; Damevska K; Nikolovska S
    Open Access Maced J Med Sci; 2018 Aug; 6(8):1458-1461. PubMed ID: 30159077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of hydroxyurea-induced leg ulcer after definitive treatment suspension in a patient affected by thrombocythemia: effectiveness of a new collagenase.
    Fioramonti P; Fino P; Parisi P; Scuderi N; Onesti MG
    In Vivo; 2012; 26(6):1053-6. PubMed ID: 23160693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hydroxyurea-induced leg ulcers in patients with chronic myeloproliferative disorders].
    Olesen LH; Pedersen BB
    Ugeskr Laeger; 2001 Dec; 163(49):6908-11. PubMed ID: 11766504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Hydroxyurea-induced Leg Ulcer.
    Hwang SW; Hong SK; Kim SH; Seo JK; Lee D; Sung HS
    Ann Dermatol; 2009 Feb; 21(1):39-41. PubMed ID: 20548853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nearly complete hair re-pigmentation in an older patient treated with hydroxyurea for essential thrombocytosis.
    Salmasi S; Hassan RA; Gafarzadeh Z; Dasanu CA
    J Oncol Pharm Pract; 2024 Sep; ():10781552241285591. PubMed ID: 39311334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanonychia Secondary to Long-Term Treatment with Hydroxycarbamide: An Essential Thrombocytosis Case.
    Malkan UY; Gunes G; Eliacik E; Yayar O; Haznedaroglu IC
    Case Rep Hematol; 2015; 2015():653178. PubMed ID: 26301108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanonychia and mucocutaneous hyperpigmentation due to hydroxyurea use in an HIV-infected patient.
    Laughon SK; Shinn LL; Nunley JR
    Int J Dermatol; 2000 Dec; 39(12):928-31. PubMed ID: 11168664
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of hydroxyurea-related cutaneous adverse events.
    Griesshammer M; Wille K; Sadjadian P; Stegelmann F; Döhner K
    Expert Opin Drug Saf; 2021 Dec; 20(12):1515-1521. PubMed ID: 34181494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.